article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. A lot of this was incremental innovation around the user interface of coding assistants that developers have been using for 25 years,” says Sonnenblick.

Biotech 487
article thumbnail

CIO Guy Hadari on the management skills that set IT leaders apart

CIO

“Most people consider the CIO to be a technology person, and they want to put them in a technology box, but technology should be only 20% of a CIO’s job,” says Hadari, who has been leading IT for the $15 billion biotech business since March 2021. A CIO with a half billion-dollar budget is essentially the CEO of a very complex business.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

Instead, a good portion of the IT organization embeds with scientists and other drug specialists to immerse in the various research initiatives, uncover the potential for IT innovation, and map the requisite technologies.

article thumbnail

Scaling a medical device company: A CIO’s digital transformation journey

CIO

I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. But you need to balance the innovation with the risk that comes along with it. From the innovation lens, I’m excited about AI. Then I started working.

Biotech 458
article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.

Biotech 98
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9

Biotech 96
article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Sponsor deals rebounded exceptionally.

Capital 98